-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Insulet, Lowers Price Target to $225

Benzinga·07/10/2026 13:15:01
Listen to the news
Stifel analyst Jonathan Block maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $250 to $225.